How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol

Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):5-7. doi: 10.1007/s00259-016-3511-5.

Author

Roland Hustinx¹

Affiliation

¹ Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, GIGA-CRC in Vivo Imaging, University of Liège, Liège, Belgium. rhustinx@chu.ulg.ac.be.

PMID: 27624189
DOI: 10.1007/s00259-016-3511-5

No abstract available

Publication types

Editorial

MeSH terms

Cost-Benefit Analysis / economics
Europe
Fluorodeoxyglucose F18
Lung Neoplasms / diagnostic imaging*
Lung Neoplasms / economics
Medical Oncology / standards
Nuclear Medicine / standards*
Patient Selection*
Positron Emission Tomography Computed Tomography / economics
Positron Emission Tomography Computed Tomography / methods
Positron Emission Tomography Computed Tomography / standards*
Practice Guidelines as Topic*
Radiopharmaceuticals
Reproducibility of Results
Sensitivity and Specificity
Solitary Pulmonary Nodule / diagnostic imaging*
Solitary Pulmonary Nodule / economics

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18